- Report
- July 2025
- 186 Pages
Global
From €4207EUR$4,650USD£3,602GBP
- Report
- December 2024
- 125 Pages
Global
From €4207EUR$4,650USD£3,602GBP
- Report
- February 2024
- 158 Pages
Global
From €4207EUR$4,650USD£3,602GBP
- Report
- November 2023
- 67 Pages
Global
From €2669EUR$2,950USD£2,285GBP
- Report
- May 2023
- 51 Pages
Global
From €2262EUR$2,500USD£1,937GBP
- Report
- March 2023
- 64 Pages
Global
From €2262EUR$2,500USD£1,937GBP
- Report
- September 2022
- 257 Pages
Global
From €4976EUR$5,500USD£4,261GBP
- Report
- May 2026
- 200 Pages
South Korea
From €2523EUR$2,789USD£2,161GBP
- Report
- July 2025
- 200 Pages
Philippines
From €2523EUR$2,789USD£2,161GBP
- Report
- July 2025
- 200 Pages
India
From €2523EUR$2,789USD£2,161GBP
- Report
- July 2025
- 122 Pages
United States
From €3256EUR$3,599USD£2,788GBP
- Report
- June 2025
- 400 Pages
Global
From €4477EUR$4,949USD£3,834GBP
- Report
- June 2025
- 400 Pages
Global
From €4477EUR$4,949USD£3,834GBP
- Report
- June 2025
- 400 Pages
Global
From €4477EUR$4,949USD£3,834GBP
- Report
- June 2025
- 400 Pages
Global
From €4477EUR$4,949USD£3,834GBP
- Report
- November 2023
- 188 Pages
Mexico
From €3256EUR$3,599USD£2,788GBP
- Report
- November 2023
- 200 Pages
Global
From €3256EUR$3,599USD£2,788GBP
- Report
- November 2023
- 170 Pages
Global
From €3256EUR$3,599USD£2,788GBP
- Report
- November 2023
- 172 Pages
Global
From €3256EUR$3,599USD£2,788GBP
- Report
- April 2023
- 147 Pages
Global
From €4477EUR$4,949USD£3,834GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more